Compared to Semaglutide and Tirzepatide, retatrutide's special inclusion of glucagon receptor agonism together with GIP and GLP-1 receptor agonism provides a definite pharmacological profile. Though Semaglutide can be a GLP-one receptor agonist and Tirzepatide combines GLP-one and GIP receptor agonism, retatrutide's triple system could perhaps give broader metabolic Positive https://corepepptides.com/product/retatrutide-injection-pen/